Eli Lilly’s New $299 Month-Long GLP‑1 Injector Shows Why It’s Winning the Weight‑Loss Race

Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo ...
eWeek

OpenAI Introduces New Safeguards in ChatGPT to Prevent AI Prompt Injection

OpenAI launches Lockdown Mode and Elevated Risk warnings to protect ChatGPT against prompt-injection attacks and reduce data-exfiltration risks.